Pages that link to "Q34063441"
Jump to navigation
Jump to search
The following pages link to Cholangiocarcinoma in patients with opisthorchiasis (Q34063441):
Displaying 24 items.
- Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma (Q27852856) (← links)
- Management of perihilar cholangiocarcinoma in the era of multimodal therapy (Q28273788) (← links)
- Telomeres and telomere dynamics: relevance to cancers of the GI tract (Q28394311) (← links)
- Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma (Q33258688) (← links)
- Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand (Q33754581) (← links)
- Liver fluke-associated cholangiocarcinoma (Q33960569) (← links)
- Cholangiocarcinoma. (Q33990595) (← links)
- Cholangiocarcinoma of the extrahepatic bile ducts (Q34110976) (← links)
- Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates (Q34186338) (← links)
- Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma (Q34224792) (← links)
- Environmental, cultural and social changes and their influence on parasite infections (Q34282196) (← links)
- Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis (Q34344162) (← links)
- Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients (Q34619353) (← links)
- Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma (Q36308639) (← links)
- Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker (Q37085618) (← links)
- Characteristics of common solid liver lesions and recommendations for diagnostic workup (Q37262038) (← links)
- Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 (Q37347327) (← links)
- Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status (Q37465737) (← links)
- Emerging pharmacotherapeutic strategies for cholangiocarcinoma (Q37876403) (← links)
- Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma (Q38707983) (← links)
- Genetic comparison of liver flukes, Clonorchis sinensis and Opisthorchis viverrini, based on rDNA and mtDNA gene sequences. (Q51805023) (← links)
- CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma. (Q53480113) (← links)
- RETRACTED: Preoperative neutrophil-to-lymphocyte ratio for prognostication of patients with distal bile duct carcinomas undergoing surgery (Q56511945) (← links)
- Update on Hepatobiliary and Pulmonary Flukes (Q73235228) (← links)